170 related articles for article (PubMed ID: 18569034)
1. Raised serum levels of matrix metalloproteinase-9 in women with polycystic ovary syndrome and its association with insulin-like growth factor binding protein-1.
Liu B; Cai LY; Lv HM; Xia L; Zhang YJ; Zhang HX; Guan YM
Gynecol Endocrinol; 2008 May; 24(5):285-8. PubMed ID: 18569034
[TBL] [Abstract][Full Text] [Related]
2. Altered regulation of insulin-like growth factor binding protein-1 in patients with polycystic ovary syndrome.
Carmina E; Stanczyk FZ; Morris RS; Lee PD; Savjani G; Lobo RA
J Soc Gynecol Investig; 1995; 2(6):743-7. PubMed ID: 9420884
[TBL] [Abstract][Full Text] [Related]
3. Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndrome.
Pawelczyk L; Spaczynski RZ; Banaszewska B; Duleba AJ
Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113(2):209-13. PubMed ID: 15063962
[TBL] [Abstract][Full Text] [Related]
4. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome.
Schoyer KD; Liu HC; Witkin S; Rosenwaks Z; Spandorfer SD
Fertil Steril; 2007 Jul; 88(1):139-44. PubMed ID: 17320874
[TBL] [Abstract][Full Text] [Related]
5. [Can hormonal contraceptives affect plasma levels of IGF-1 and IGFBP-1 in slim women with polycystic ovary syndrome?].
Sindelka G; Cibula D; Fanta M; Kasalová Z; Justová V; Lacinová Z; Skrha J
Cas Lek Cesk; 2001 Aug; 140(15):469-72. PubMed ID: 11569168
[TBL] [Abstract][Full Text] [Related]
6. IGF-1, IGFBP-3, VEGF and MMP-9 levels and their potential relationship with renal functions in patients with compensatory renal growth.
Yildiz B; Kural N; Colak O; Ak I; Akcar N
Clin Physiol Funct Imaging; 2008 Mar; 28(2):107-12. PubMed ID: 18093232
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor and insulin-like growth factor-1 in polycystic ovary syndrome and their relation to ovarian blood flow.
Abd El Aal DE; Mohamed SA; Amine AF; Meki AR
Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):219-24. PubMed ID: 15653207
[TBL] [Abstract][Full Text] [Related]
8. Gelatinase A (MM-2), gelatinase B (MMP-9) and their inhibitors (TIMP 1, TIMP-2) in serum of women with endometriosis: Significant correlation between MMP-2, MMP-9 and their inhibitors without difference in levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in relation to the severity of endometriosis.
Salata IM; Stojanovic N; Cajdler-Łuba A; Lewandowski KC; Lewiński A
Gynecol Endocrinol; 2008 Jun; 24(6):326-30. PubMed ID: 18584412
[TBL] [Abstract][Full Text] [Related]
9. Oral contraceptive containing chlormadinone acetate and ethinylestradiol reduces plasma concentrations of matrix metalloproteinase-2 in women with polycystic ovary syndrome.
Gomes VA; Vieira CS; Jacob-Ferreira AL; Belo VA; Soares GM; França JB; Ferriani RA; Tanus-Santos JE
Basic Clin Pharmacol Toxicol; 2012 Sep; 111(3):211-6. PubMed ID: 22510229
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloprotease-3 and -9 proteolyze insulin-like growth factor-binding protein-1.
Coppock HA; White A; Aplin JD; Westwood M
Biol Reprod; 2004 Aug; 71(2):438-43. PubMed ID: 15070833
[TBL] [Abstract][Full Text] [Related]
11. Serum insulin-like growth factor-axis and matrix metalloproteinases in patients with rheumatic arthritis or rheumatic heart disease.
Lee SD; Chen LM; Kuo WW; Shu WT; Kuo WH; Huang EJ; Tsai CC; Li PC; Liu JY; Chen TH; Huang CY
Clin Chim Acta; 2006 May; 367(1-2):62-8. PubMed ID: 16406300
[TBL] [Abstract][Full Text] [Related]
12. Increased circulating levels of matrix metalloproteinase-2 and -9 in women with the polycystic ovary syndrome.
Lewandowski KC; Komorowski J; O'Callaghan CJ; Tan BK; Chen J; Prelevic GM; Randeva HS
J Clin Endocrinol Metab; 2006 Mar; 91(3):1173-7. PubMed ID: 16338908
[TBL] [Abstract][Full Text] [Related]
13. Regulation of human villous trophoblast by insulin-like growth factors and insulin-like growth factor-binding protein-1.
Hills FA; Elder MG; Chard T; Sullivan MH
J Endocrinol; 2004 Dec; 183(3):487-96. PubMed ID: 15590975
[TBL] [Abstract][Full Text] [Related]
14. Role of growth hormone in polycystic ovarian syndrome.
Morales AJ
Semin Reprod Endocrinol; 1997 May; 15(2):177-82. PubMed ID: 9165661
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases 2 and 9 and their tissue inhibitors in the follicular fluid of patients with polycystic ovaries undergoing in vitro fertilisation.
Baka S; Zourla K; Kouskouni E; Makrakis E; Demeridou S; Tzanakaki D; Hassiakos D; Creatsas G
In Vivo; 2010; 24(3):293-6. PubMed ID: 20555001
[TBL] [Abstract][Full Text] [Related]
16. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension.
Tan J; Hua Q; Xing X; Wen J; Liu R; Yang Z
Hypertens Res; 2007 Oct; 30(10):959-63. PubMed ID: 18049028
[TBL] [Abstract][Full Text] [Related]
17. Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.
Serin IS; Tanriverdi F; Yilmaz MO; Ozcelik B; Unluhizarci K
Gynecol Endocrinol; 2008 Mar; 24(3):117-21. PubMed ID: 18335323
[TBL] [Abstract][Full Text] [Related]
18. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
Pehlivanov B; Mitkov M
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
[TBL] [Abstract][Full Text] [Related]
19. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
Gravholt CH; Chen JW; Oxvig C; Overgaard MT; Christiansen JS; Frystyk J; Flyvbjerg A
Growth Horm IGF Res; 2006; 16(5-6):332-9. PubMed ID: 17067837
[TBL] [Abstract][Full Text] [Related]
20. Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer.
Gallego R; Codony-Servat J; García-Albéniz X; Carcereny E; Longarón R; Oliveras A; Tosca M; Augé JM; Gascón P; Maurel J
Endocr Relat Cancer; 2009 Mar; 16(1):311-7. PubMed ID: 19109398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
